Guillou-Landreat, M.; Dany, A.; Challet-Bouju, G.; Laforgue, E.; Leboucher, J.; Benoit Hardouin, J.; Victorri-Vigneau, C.; Grall-Bronnec, M.
What Differs between Patients under Methadone and under Buprenorphine for Opioid Use Disorder (OUD) in Daily Clinical Practice in France? A Short Report. Int. J. Environ. Res. Public Health 2021, 18, 1425.
https://doi.org/10.3390/ijerph18041425
AMA Style
Guillou-Landreat M, Dany A, Challet-Bouju G, Laforgue E, Leboucher J, Benoit Hardouin J, Victorri-Vigneau C, Grall-Bronnec M.
What Differs between Patients under Methadone and under Buprenorphine for Opioid Use Disorder (OUD) in Daily Clinical Practice in France? A Short Report. International Journal of Environmental Research and Public Health. 2021; 18(4):1425.
https://doi.org/10.3390/ijerph18041425
Chicago/Turabian Style
Guillou-Landreat, Morgane, Antoine Dany, Gaëlle Challet-Bouju, Edouard Laforgue, Juliette Leboucher, Jean Benoit Hardouin, Caroline Victorri-Vigneau, and Marie Grall-Bronnec.
2021. "What Differs between Patients under Methadone and under Buprenorphine for Opioid Use Disorder (OUD) in Daily Clinical Practice in France? A Short Report" International Journal of Environmental Research and Public Health 18, no. 4: 1425.
https://doi.org/10.3390/ijerph18041425
APA Style
Guillou-Landreat, M., Dany, A., Challet-Bouju, G., Laforgue, E., Leboucher, J., Benoit Hardouin, J., Victorri-Vigneau, C., & Grall-Bronnec, M.
(2021). What Differs between Patients under Methadone and under Buprenorphine for Opioid Use Disorder (OUD) in Daily Clinical Practice in France? A Short Report. International Journal of Environmental Research and Public Health, 18(4), 1425.
https://doi.org/10.3390/ijerph18041425